These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8218954)

  • 1. HIV-1-induced immune suppression may result from autoimmune disorders including anti-SLWDQ autoantibodies.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Cantalloube H
    Biomed Pharmacother; 1993; 47(2-3):93-9. PubMed ID: 8218954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striking similarities between HIV-1 Env protein and the apoptosis mediating cell surface antigen Fas. Role in the pathogenesis of AIDS.
    Zagury JF; Cantalloube H; Achour A; Cho YY; Fall L; Lachgar A; Chams V; Astgen A; Biou D; Picard O
    Biomed Pharmacother; 1993; 47(8):331-5. PubMed ID: 7520296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDS.
    Zagury JF; Lachgar A; Achour A; Chams-Harvey V; Cho YY; Le Coq H; Bizzini B; Feldman M; Burny A; Zagury D
    Biomed Pharmacother; 1994; 48(1):11-6. PubMed ID: 7919098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of purified IgGs from HIV-1-infected and non infected individuals on immune activation.
    Chams V; Biou D; Cho YY; Mbika JP; Le Coq H; Heshmati F; Fouchard M; Bizzini B; Zagury JF
    Biomed Pharmacother; 1994; 48(5-6):267-72. PubMed ID: 7999989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans.
    Kang CY; Nara P; Chamat S; Caralli V; Ryskamp T; Haigwood N; Newman R; Köhler H
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6171-5. PubMed ID: 2068099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mimicry in the pathogenesis of AIDS: the HIV/MHC/mycoplasma triangle.
    Bisset LR
    Med Hypotheses; 1994 Dec; 43(6):388-96. PubMed ID: 7739411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-lymphocyte antibodies in plasma of HIV-1-infected patients preferentially react with MHC class II-negative T cells and are linked to antibodies against gp41.
    Müller C; Kukel S; Schneweis KE; Bauer R
    Clin Exp Immunol; 1994 Sep; 97(3):367-72. PubMed ID: 8082291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.
    Golding H; Robey FA; Gates FT; Linder W; Beining PR; Hoffman T; Golding B
    J Exp Med; 1988 Mar; 167(3):914-23. PubMed ID: 3127528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort.
    Fink E; Fuller K; Agan B; Berger EA; Saphire A; Quinnan GV; Elder JH
    AIDS Res Hum Retroviruses; 2016 Dec; 32(12):1187-1197. PubMed ID: 27771962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation.
    Mittler RS; Hoffmann MK
    Science; 1989 Sep; 245(4924):1380-2. PubMed ID: 2571187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS pathogenesis: HIV envelope and its interaction with cell proteins.
    Habeshaw JA; Dalgleish AG; Bountiff L; Newell AL; Wilks D; Walker LC; Manca F
    Immunol Today; 1990 Nov; 11(11):418-25. PubMed ID: 2078296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A response to P.H. Duesberg with reference to an idiotypic network model of AIDS immunopathogenesis.
    Hoffmann GW
    Res Immunol; 1990 Oct; 141(8):701-9. PubMed ID: 2089529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological properties of anti-CD4 autoantibodies purified from HIV-infected patients.
    Chams V; Idziorek T; Klatzmann D
    AIDS; 1991 May; 5(5):565-9. PubMed ID: 1677809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis?
    Zagury JF; Chams V; Lachgar A; Achour A; Bizzini B; Burny A; Zagury D; Feldman M
    Cell Death Differ; 1995 Jan; 2(1):23-32. PubMed ID: 17180012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 peptide-protein conjugates, but not recombinant human CD4, bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients.
    Ghetie V; Slaughter C; Wheeler HT; Uhr JW; Vitetta ES
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5690-3. PubMed ID: 2062847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of immunodeficiency in HIV infection and ways of overcoming it].
    Brondz BD; Zaĭtseva MB; Kozhich AT; Moshnikov SA; Makarova OD; Frolova EA
    Genetika; 1992 Jul; 28(7):19-26. PubMed ID: 1427054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates.
    Devico A; Silver A; Thronton AM; Sarngadharan MG; Pal R
    Virology; 1996 Apr; 218(1):258-63. PubMed ID: 8615032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in HIV-infected hemophilia patients against different epitopes on CD4+ lymphocytes and recombinant CD4.
    Daniel V; Weimer R; Zettlmeissl G; Langner K; Zimmermann R; Opelz G
    Vox Sang; 1992; 62(1):39-44. PubMed ID: 1374580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.